Which vendors make up a clinical supply chain?

Typically CDMOs for manufacturing, packaging/labeling providers, depot and distribution networks, specialty couriers, IRT/RTSM vendors, and comparator sourcing partners — coordinated by the sponsor or an integrated service provider.

Should sponsors use one integrated vendor or best-of-breed specialists?

Integration simplifies coordination and accountability; specialists offer depth and reduce concentration risk. The right answer depends on internal capacity to coordinate — the mistake is inheriting a model by default rather than choosing one.

What KPIs matter most for supply vendors?

On-time-in-full delivery, temperature excursion rates by lane, inventory accuracy, documentation quality, change-order turnaround, and communication speed on exceptions — all contractually defined and dashboard-visible.

How often should clinical supply vendors be audited?

On a risk-based cycle — more frequently for critical, GMP-touching, or historically weak performers — supplemented by for-cause audits when performance signals warrant, and continuous KPI monitoring between audits.

Vendor Management

Clinical Supply Vendor Management: Choosing Partners Well and Governing Them Better

By Juan Hernandez, PresidentSeptember 9, 2026

Almost no sponsor runs its own clinical supply chain end to end. Manufacturing sits with CDMOs, packaging and labeling with specialist providers, storage and distribution with depot networks, transport with couriers, and systems with IRT vendors — a federation of companies whose coordinated performance is your supply chain. That makes vendor selection and oversight the sponsor's real core competency: you can outsource the work, but you can never outsource the accountability. The programs that run smoothly aren't the ones with perfect vendors; they're the ones with deliberate selection, clear contracts, and governance that catches drift early.

What does the clinical supply vendor ecosystem actually look like?

Six seats at the table, each with different failure modes. CDMOs (drug substance/product manufacture) — long lead times, capacity queues, technical transfer risk. Packaging and labeling providers — schedule reliability and change responsiveness, tested hardest by amendments and relabeling. Depot networks — licensing coverage, storage compliance, inventory accuracy. Specialty couriers — lane performance, intervention capability when shipments go sideways, the front line of your excursion record. IRT vendors — configuration quality, change turnaround, support responsiveness. Comparator sourcing partners — authenticity, pricing transparency, supply reliability. Some sponsors bundle several seats with one integrated provider; the integration convenience is real, and so is the concentration risk. Neither model is right — but whichever you choose should be chosen, not defaulted into.

How should vendors be selected — beyond the audit checklist?

Quality audits are necessary and insufficient: they verify a vendor can comply, not that they'll perform for you. The selection questions that predict lived experience:

Fit of scale. Are you a top-30% client or rounding error? Small biotechs at giant vendors get giant-vendor priority; the right-sized partner answers your emails.
Experience with your specifics. Your modality's cold chain, your countries, your trial design. Ask for scars, not brochures: "Tell us about the last time this went wrong and what you did."
Change behavior. How do they price and turn around changes? Clinical supply is change management; a vendor rigid on change orders will hurt you at every amendment.
Transparency instincts. In references, probe one thing above all: do they surface problems early or manage the narrative? You are buying their behavior on a bad day.
The network behind them. Depots and couriers especially — whose licenses, whose trucks, whose subcontractors actually touch your product?

What belongs in the contract that usually isn't there?

The operating agreement, not just the legal one. Beyond scope and price: named KPIs with definitions (on-time-in-full, excursion rates by lane, inventory accuracy, system uptime, change-order turnaround) and the data feeds to measure them; communication SLAs — who is notified of what, how fast, at 2 a.m.; change pricing frameworks agreed before the first change; business continuity commitments — backup sites, disaster plans, and your rights if they fail; exit provisions — data, stock, and technical transfer terms that make leaving possible, because a vendor you can't leave is a vendor you can't govern. None of this is adversarial; it's the shared definition of "good" that makes the relationship governable.

What does oversight look like without micromanagement?

A rhythm, not a leash:

Operational cadence — weekly or biweekly working-level calls during active periods, driven by a shared dashboard of the contracted KPIs, not by anecdote.
Quarterly business reviews — trends, root causes of misses, upcoming volume changes, improvement commitments with owners and dates.
Risk-based requalification — periodic audits scaled to criticality and performance history, plus for-cause audits triggered by signals, not schedules.
Issue escalation with memory — every significant failure gets a root cause and a CAPA tracked to closure; the vendor file is a learning record, not a filing obligation.
Relationship investment — site visits, introductions beyond the account manager, and honest sharing of your pipeline. Vendors plan capacity for sponsors they know; strangers get the queue.

And the meta-discipline: keep enough internal (or expert-partner) competence to be an intelligent customer. A sponsor who can't evaluate a vendor's answers has delegated not just work but judgment — and judgment is the one thing that must stay home.

Frequently asked questions

Which vendors make up a clinical supply chain?: Typically CDMOs for manufacturing, packaging/labeling providers, depot and distribution networks, specialty couriers, IRT/RTSM vendors, and comparator sourcing partners — coordinated by the sponsor or an integrated service provider.
Should sponsors use one integrated vendor or best-of-breed specialists?: Integration simplifies coordination and accountability; specialists offer depth and reduce concentration risk. The right answer depends on internal capacity to coordinate — the mistake is inheriting a model by default rather than choosing one.
What KPIs matter most for supply vendors?: On-time-in-full delivery, temperature excursion rates by lane, inventory accuracy, documentation quality, change-order turnaround, and communication speed on exceptions — all contractually defined and dashboard-visible.
How often should clinical supply vendors be audited?: On a risk-based cycle — more frequently for critical, GMP-touching, or historically weak performers — supplemented by for-cause audits when performance signals warrant, and continuous KPI monitoring between audits.